FAQ

1. What Is Okra Medical’s Mission And Purpose As A Company?
To improve public health by bridging science and innovation to impact the social problem of addiction to controlled substances.

We believe preventing even one person from going down the path of drug addiction is one step to a larger victory. We are addressing the problem at its source.

2. Are Okra Medical’s SafeMedWaste Products Environmentally Safe For Disposal In Landfills?
Yes. All SafeMedWaste products only use denaturants that are safe for disposal in trash receptacles and all of our products use recycled plastics and biodegradable materials to ensure environmental sustainability. We have also conducted leaching studies to ensure that chemicals used in our SafeMedWaste product suite will not harm the environment, and to ensure that addictive substances remain inert.

​3. What Makes SafeMedWaste Distinctive?
SafeMedWaste has solved the problem of disposing of addictive substances by chemically destroying (denaturing) them to the point that they are unavailable for abuse and ensuring they are 100% non-retrievable.

Our state-of-the-art patent-pending drug denaturing technology offers a DEA-compliant method to destroy controlled substances and significantly reduce their disposal costs.

4. What Impact Can Okra Medical Have On Opioid Abuse Given The Extent Of That Epidemic?
Okra Medical products have been developed to limit the accessibility of controlled substances throughout the entire supply chain – starting with pharmaceutical manufacturers to patient care clinics. Our SafeMedWaste products safely render controlled substance waste inert, both physiologically and environmentally. We are proud to introduce an important advancement toward limiting unintended accessibility of addictive controlled substances, including opioids.

5. Why Is Non-Retrievable Drug Denaturing Necessary?
The use and abuse of both prescription and illicit drugs has increased dramatically in recent years and has become a major public health concern. According to the Centers for Disease Control and Prevention, the number of overdose deaths involving opioids, both prescription and heroin, has quadrupled since 1999. In the US alone, over 42,000 people died from overdose in 2017. Most alarming is the increased accessibility of addictive opioids. Therefore, drug diversion has become a major focus in the medical field, which has inspired regulatory agencies to increase oversight. The FDA and DEA are focused on the misuse of controlled substances and regulate accordingly. The FDA regulations state that healthcare facilities render controlled substance waste as “non-recoverable” while the DEA requires controlled substance waste to be rendered “non-retrievable” (DEA, 2014). A controlled substance is considered “non-retrievable” when it cannot be transformed to a physical or chemical condition or state as a controlled substance.